NCT04751136View on ClinicalTrials.gov

the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

February 28, 2019

Study Completion Date

August 30, 2019

Conditions
Down Syndrome
Interventions
DRUG

cerebrolysin

Infants of the treatment group were given Cerebrolysin in a dose of 0.1 ml / kg body weight once weekly intramuscular injection for 12 month (total of 48 injections).Each selected infant, in both treatment and control group, was assessed as regard: Socioeconomic status, Nutritional status and feeding practice, assessed for neurocognitive development

Trial Locations (1)

35516

Mansoura University Children Hospital, Al Mansurah

All Listed Sponsors
lead

Mansoura University Children Hospital

OTHER

NCT04751136 - the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome | Biotech Hunter | Biotech Hunter